TickerFactsScreenerDevelopers

Annovis Bio, Inc. (ANVS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$476.5K2020: -$3.97M2021: -$9.13M2022: -$17.31M2023: -$39.97M2024: -$21.89M2025: -$25.62M-$25.62M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$25.62M-17.0%
2024-$21.89M+45.2%
2023-$39.97M-130.9%
2022-$17.31M-89.6%
2021-$9.13M-130.0%
2020-$3.97M-733.3%
2019-$476.5K—